Cargando…

Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study

OBJECTIVE: Systemic sclerosis (SSc) is a rare and clinically heterogeneous autoimmune disorder characterised by fibrosis and microvascular obliteration of the skin and internal organs. Organ involvement mostly manifests after a variable period of the onset of Raynaud's phenomenon (RP). We aimed...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaeger, Veronika K., Wirz, Elina G., Allanore, Yannick, Rossbach, Philipp, Riemekasten, Gabriela, Hachulla, Eric, Distler, Oliver, Airò, Paolo, Carreira, Patricia E., Balbir Gurman, Alexandra, Tikly, Mohammed, Vettori, Serena, Damjanov, Nemanja, Müller-Ladner, Ulf, Distler, Jörg H. W., Li, Mangtao, Walker, Ulrich A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5051961/
https://www.ncbi.nlm.nih.gov/pubmed/27706206
http://dx.doi.org/10.1371/journal.pone.0163894
_version_ 1782458170854080512
author Jaeger, Veronika K.
Wirz, Elina G.
Allanore, Yannick
Rossbach, Philipp
Riemekasten, Gabriela
Hachulla, Eric
Distler, Oliver
Airò, Paolo
Carreira, Patricia E.
Balbir Gurman, Alexandra
Tikly, Mohammed
Vettori, Serena
Damjanov, Nemanja
Müller-Ladner, Ulf
Distler, Jörg H. W.
Li, Mangtao
Walker, Ulrich A.
author_facet Jaeger, Veronika K.
Wirz, Elina G.
Allanore, Yannick
Rossbach, Philipp
Riemekasten, Gabriela
Hachulla, Eric
Distler, Oliver
Airò, Paolo
Carreira, Patricia E.
Balbir Gurman, Alexandra
Tikly, Mohammed
Vettori, Serena
Damjanov, Nemanja
Müller-Ladner, Ulf
Distler, Jörg H. W.
Li, Mangtao
Walker, Ulrich A.
author_sort Jaeger, Veronika K.
collection PubMed
description OBJECTIVE: Systemic sclerosis (SSc) is a rare and clinically heterogeneous autoimmune disorder characterised by fibrosis and microvascular obliteration of the skin and internal organs. Organ involvement mostly manifests after a variable period of the onset of Raynaud's phenomenon (RP). We aimed to map the incidence and predictors of pulmonary, cardiac, gastrointestinal (GI) and renal involvement in the early course of SSc. METHODS: In the EUSTAR cohort, patients with early SSc were identified as those who had a visit within the first year after RP onset. Incident SSc organ manifestations and their risk factors were assessed using Kaplan-Meier methods and Cox regression analysis. RESULTS: Of the 695 SSc patients who had a baseline visit within 1 year after RP onset, the incident non-RP manifestations (in order of frequency) were: skin sclerosis (75%) GI symptoms (71%), impaired diffusing capacity for monoxide<80% predicted (65%), DU (34%), cardiac involvement (32%), FVC<80% predicted (31%), increased PAPsys>40mmHg (14%), and renal crisis (3%). In the heart, incidence rates were highest for diastolic dysfunction, followed by conduction blocks and pericardial effusion. While the main baseline risk factor for a short timespan to develop FVC impairment was diffuse skin involvement, for PAPsys>40mmHg it was higher patient age. The main risk factors for incident cardiac manifestations were anti-topoisomerase autoantibody positivity and older age. Male sex, anti-RNA-polymerase-III positivity, and older age were risk factors associated with incident renal crisis. CONCLUSION: In SSc patients presenting early after RP onset, approximately half of all incident organ manifestations occur within 2 years and have a simultaneous rather than a sequential onset. These findings have implications for the design of new diagnostic and therapeutic strategies aimed to ‘widen' the still very narrow ‘window of opportunity'. They may also enable physicians to counsel and manage patients presenting early in the course of SSc more accurately.
format Online
Article
Text
id pubmed-5051961
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-50519612016-10-27 Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study Jaeger, Veronika K. Wirz, Elina G. Allanore, Yannick Rossbach, Philipp Riemekasten, Gabriela Hachulla, Eric Distler, Oliver Airò, Paolo Carreira, Patricia E. Balbir Gurman, Alexandra Tikly, Mohammed Vettori, Serena Damjanov, Nemanja Müller-Ladner, Ulf Distler, Jörg H. W. Li, Mangtao Walker, Ulrich A. PLoS One Research Article OBJECTIVE: Systemic sclerosis (SSc) is a rare and clinically heterogeneous autoimmune disorder characterised by fibrosis and microvascular obliteration of the skin and internal organs. Organ involvement mostly manifests after a variable period of the onset of Raynaud's phenomenon (RP). We aimed to map the incidence and predictors of pulmonary, cardiac, gastrointestinal (GI) and renal involvement in the early course of SSc. METHODS: In the EUSTAR cohort, patients with early SSc were identified as those who had a visit within the first year after RP onset. Incident SSc organ manifestations and their risk factors were assessed using Kaplan-Meier methods and Cox regression analysis. RESULTS: Of the 695 SSc patients who had a baseline visit within 1 year after RP onset, the incident non-RP manifestations (in order of frequency) were: skin sclerosis (75%) GI symptoms (71%), impaired diffusing capacity for monoxide<80% predicted (65%), DU (34%), cardiac involvement (32%), FVC<80% predicted (31%), increased PAPsys>40mmHg (14%), and renal crisis (3%). In the heart, incidence rates were highest for diastolic dysfunction, followed by conduction blocks and pericardial effusion. While the main baseline risk factor for a short timespan to develop FVC impairment was diffuse skin involvement, for PAPsys>40mmHg it was higher patient age. The main risk factors for incident cardiac manifestations were anti-topoisomerase autoantibody positivity and older age. Male sex, anti-RNA-polymerase-III positivity, and older age were risk factors associated with incident renal crisis. CONCLUSION: In SSc patients presenting early after RP onset, approximately half of all incident organ manifestations occur within 2 years and have a simultaneous rather than a sequential onset. These findings have implications for the design of new diagnostic and therapeutic strategies aimed to ‘widen' the still very narrow ‘window of opportunity'. They may also enable physicians to counsel and manage patients presenting early in the course of SSc more accurately. Public Library of Science 2016-10-05 /pmc/articles/PMC5051961/ /pubmed/27706206 http://dx.doi.org/10.1371/journal.pone.0163894 Text en © 2016 Jaeger et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Jaeger, Veronika K.
Wirz, Elina G.
Allanore, Yannick
Rossbach, Philipp
Riemekasten, Gabriela
Hachulla, Eric
Distler, Oliver
Airò, Paolo
Carreira, Patricia E.
Balbir Gurman, Alexandra
Tikly, Mohammed
Vettori, Serena
Damjanov, Nemanja
Müller-Ladner, Ulf
Distler, Jörg H. W.
Li, Mangtao
Walker, Ulrich A.
Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study
title Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study
title_full Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study
title_fullStr Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study
title_full_unstemmed Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study
title_short Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study
title_sort incidences and risk factors of organ manifestations in the early course of systemic sclerosis: a longitudinal eustar study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5051961/
https://www.ncbi.nlm.nih.gov/pubmed/27706206
http://dx.doi.org/10.1371/journal.pone.0163894
work_keys_str_mv AT jaegerveronikak incidencesandriskfactorsoforganmanifestationsintheearlycourseofsystemicsclerosisalongitudinaleustarstudy
AT wirzelinag incidencesandriskfactorsoforganmanifestationsintheearlycourseofsystemicsclerosisalongitudinaleustarstudy
AT allanoreyannick incidencesandriskfactorsoforganmanifestationsintheearlycourseofsystemicsclerosisalongitudinaleustarstudy
AT rossbachphilipp incidencesandriskfactorsoforganmanifestationsintheearlycourseofsystemicsclerosisalongitudinaleustarstudy
AT riemekastengabriela incidencesandriskfactorsoforganmanifestationsintheearlycourseofsystemicsclerosisalongitudinaleustarstudy
AT hachullaeric incidencesandriskfactorsoforganmanifestationsintheearlycourseofsystemicsclerosisalongitudinaleustarstudy
AT distleroliver incidencesandriskfactorsoforganmanifestationsintheearlycourseofsystemicsclerosisalongitudinaleustarstudy
AT airopaolo incidencesandriskfactorsoforganmanifestationsintheearlycourseofsystemicsclerosisalongitudinaleustarstudy
AT carreirapatriciae incidencesandriskfactorsoforganmanifestationsintheearlycourseofsystemicsclerosisalongitudinaleustarstudy
AT balbirgurmanalexandra incidencesandriskfactorsoforganmanifestationsintheearlycourseofsystemicsclerosisalongitudinaleustarstudy
AT tiklymohammed incidencesandriskfactorsoforganmanifestationsintheearlycourseofsystemicsclerosisalongitudinaleustarstudy
AT vettoriserena incidencesandriskfactorsoforganmanifestationsintheearlycourseofsystemicsclerosisalongitudinaleustarstudy
AT damjanovnemanja incidencesandriskfactorsoforganmanifestationsintheearlycourseofsystemicsclerosisalongitudinaleustarstudy
AT mullerladnerulf incidencesandriskfactorsoforganmanifestationsintheearlycourseofsystemicsclerosisalongitudinaleustarstudy
AT distlerjorghw incidencesandriskfactorsoforganmanifestationsintheearlycourseofsystemicsclerosisalongitudinaleustarstudy
AT limangtao incidencesandriskfactorsoforganmanifestationsintheearlycourseofsystemicsclerosisalongitudinaleustarstudy
AT walkerulricha incidencesandriskfactorsoforganmanifestationsintheearlycourseofsystemicsclerosisalongitudinaleustarstudy
AT incidencesandriskfactorsoforganmanifestationsintheearlycourseofsystemicsclerosisalongitudinaleustarstudy